Skip to content
2000
Volume 23, Issue 1
  • ISSN: 1871-5249
  • E-ISSN: 1875-6166

Abstract

Introduction: Toxoplasmosis and narcotic drug addiction are endemic in various regions of Iran. These drugs can provide situations for infections by disrupting the immune system. The current case-control study was designed to determine the prevalence of toxoplasmosis in narcotic drugaddicted persons in comparison with healthy subjects using serology and molecular techniques in the southwest of Iran. Methods: A total of 201 subjects (including 101 individuals with drug addiction and 100 control participants) were randomly selected. Chronic and acute toxoplasmosis was detected using the enzymelinked immunosorbent assay (ELISA) IgG avidity. immunoglobulin G (IgG) and immunoglobulin M (IgM) were also determined by the ELISA. Moreover, the presence of in blood samples was diagnosed using the nested-polymerase chain reaction (Nested-PCR). Results: For IgG, 17 (17.0%) of 100 and 39 (38.6%) of 101 cases were diagnosed in the control participants and drug-addicted people, respectively [P=0.001, OR=3.071, CI= (1.591-5.929)]. Moreover, 16 (15.8) and 5 (5.0%) cases were positive for the B1 gene in the drug-addicted patients and controls by the nested-PCR technique, respectively [P=0.019, OR=3.576, CI= (1.257-10.179)]. However, no significant differences were found between the opium (n=64) and crystal methamphetamine (n=37) groups in terms of IgG and IgM antibodies and the presence of the parasite in the blood (>0.05). Conclusion: The present results demonstrated that the outbreak of the infection was more frequent in narcotic drug-addicted persons than the controls using serology and molecular techniques.

Loading

Article metrics loading...

/content/journals/cnsamc/10.2174/1871524923666230131152727
2023-04-01
2025-09-03
Loading full text...

Full text loading...

/content/journals/cnsamc/10.2174/1871524923666230131152727
Loading

  • Article Type:
    Research Article
Keyword(s): antibodies; drug-addicted persons; immune system; narcotic; Toxoplasma gondii; toxoplasmosis
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test